Clinical trial

Mosquito
#Clinical trial #Immunology / Virology & Vaccines #Malaria #Research #Vaccines

Malaria vaccine first to achieve WHO-specified 75% efficacy goal

Researchers from the University of Oxford and their partners have reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy of 77% over 12-months of follow-up. In their findings (posted on SSRN/Preprints with The Lancet), they note that they are the first to… Read More

#News

#Clinical trial #Drug delivery #Drug development #Drug discovery #Gene therapy

Genethon doses first patient in clinical trial of gene therapy for DMD

The first dose of the investigational gene therapy GNT 0004 was given for Dunchenne Muscular Dystrophy (DMD) at I-Motion, the paediatric clinical trial platform for neuromuscular diseases in Paris. The young boy was the first patient in an international phase I/II/III multicentre trial, sponsored by Genethon. The trial has been… Read More

#News

#Antibodies #Clinical trial #Covid-19 #Immunology / Virology & Vaccines

Trial begins of antibody to treat Covid-19 respiratory disease

A clinical trial testing the safety and efficacy of an investigational monoclonal antibody for treating people who are hospitalised with respiratory disease and low blood oxygen due to infection with SARS-CoV-2, the virus that causes Covid-19, has begun. The Phase II trial, called the Covid-19 anti-CD14 Treatment Trial (CaTT), is… Read More

#Covid-19 #News

#Clinical trial #Depression #Drug development #Drug discovery #Research

Magic mushroom compound performs as well as leading antidepressant

In a small study carried out by researchers at the Centre for Psychedelic Research at Imperial College London, it was found that psilocybin, the active compound in magic mushrooms, may be at least as effective as a leading antidepressant medication in a therapeutic setting. In a rigorous trial which assessed… Read More

#News

#Cancer #Cancer research #Clinical trial #Drug development #Drug discovery

Virus therapy shows promise against inoperable skin cancers

Early results show that a new combination drug therapy is safe and effective against advanced skin cancer in patients who were unable to have their tumours surgically removed. Researchers say that the drug combination is among the first to demonstrate the potential value of a live common cold virus, a… Read More

#Cancer Research #News

#Clinical trial #Covid-19 #Drug development #Immunology / Virology & Vaccines #Research #Vaccines

NIH begins study of allergic reactions to Covid-19 vaccines

A clinical trial is underway to determine whether people who are highly allergic or have a mast cell disorder are at increased risk for an immediate, systemic allergic reaction to the Moderna or Pfizer-BioNTech Covid-19 vaccines. A systemic allergic reaction to a vaccine occurs in one or more parts of… Read More

#Covid-19 #News

#Clinical trial #Covid-19 #Immunology / Virology & Vaccines #mRNA #Vaccines

New study provides global analysis of Covid-19 vaccines

A new study by Novateur Ventures provides a comparative analysis of twelve Covid-19 vaccines that had initiated or announced the Phase III clinical trial stage by early November 2020. The study highlights the early successes, as well as the hurdles and barriers yet to be overcome for ending the global… Read More

#Covid-19 #News

#Clinical trial #Covid-19 #Drug development #Drug discovery #Immunology / Virology & Vaccines

Novavax initiates Covid-19 vaccine clinical trial crossover

Biotech company Novavax has announced the initiation of crossover arms in two ongoing clinical trials of NVX-CoV2373, the company’s Covid-19 vaccine candidate. Crossover ensures the administration of active vaccine to all participants in the trials and has begun for Novavax’ Phase IIb trial in South Africa and its pivotal Phase… Read More

#Covid-19 #Editor's Choice #News #Trending News

#AI / data analytics / healthtech / informatics #Clinical trial #Drug efficacy #Regulatory

Novadiscovery collaborate with Takeda for new clinical simulation

Novadiscovery (NOVA), a health tech company offering JINKO, a clinical trial simulation platform to predict drug efficacy and optimise clinical trial development, has announced its new collaboration with Takeda Pharmaceutical. This is aimed at incorporating clinical simulation technology on virtual patients into Takeda France’s access strategy and building on an… Read More

#News

#Cancer #Clinical trial #Life sciences #Novel therapeutics #Oncology

SignalChem collaborates with Merck on advanced non-small cell lung cancer

SignalChem Lifesciences, a clinical-stage company who develop novel targeted therapies for oncology, has announced its collaboration with Merck, through a subsidiary, to evaluate the combination of SLC-391, a selective AXL inhibitor developed by SignalChem, with KEYTRUDA (pembrolizumab), Merck’s anti-PD-1 therapy, in patients with advanced non-small cell lung cancer (NSCLC). AXL,… Read More

#Cancer Research #News

#AstraZeneca #Clinical trial #Covid-19 #Immunology / Virology & Vaccines

Oxford-AstraZeneca US vaccine trial data may be outdated

The Data and Safety Monitoring Board (DSMB) has notified the National Institute of Allergy and Infectious Diseases (NIAID), Biomedical Advanced Research and Development Authority (BARDA), and AstraZeneca that it is “concerned by information released by AstraZeneca on initial data from its COVID-19 vaccine clinical trial”. Trial volunteers received two standard… Read More

#Covid-19 #Editor's Choice #News #Trending News

#AI / data analytics / healthtech / informatics #Clinical trial #Data #Drug development #Drug discovery #Report

Report promotes the use of synthetic data in clinical trials

Phesi, provider of AI-powered clinical development analytics products and solutions, and Accenture, a services and consulting company, have released the first of a series of reports exploring the use of synthetic data in clinical development. In recent years, the volume of data created through clinical trials and electronic patient records… Read More

#News

#Bayesian #Clinical trial #Drug delivery

New platform aims to simplify access to Bayesian clinical trial designs

Cytel, provider of statistical software and advanced analytics for clinical trial design and execution, has launched East Bayes, an web-based extension of the East platform that enables adoption of the most computationally intensive Bayesian clinical trial designs, without the need for powerful on-site computers. The launch expands East’s range of… Read More

#News

#Clinical trial #Covid-19 #Immunology / Virology & Vaccines #mRNA

Sanofi and Translate Bio begin clinical trial of COVID-19 vaccine

Sanofi Pasteurand Translate Bio, a clinical-stage mRNA therapeutics company, have announced the start of the Phase I/II clinical trial for MRT5500, an mRNA vaccine candidate against SARS-CoV-2. The companies expect interim results from this trial in the third quarter of 2021. Thomas Triomphe, Executive Vice President and Global Head of… Read More

#Covid-19 #News